About Vizenlifesciences
Vizenlifesciences is a Healthcare company based in India. It operates as a pharmacovigilance services including safety monitoring and adverse event reporting for pharma firms. It operates on a B2B model. The company has 116 employees. Its Indian entity Vizen Life Sciences Private Limited reported revenue of ₹13.73 Cr. Vizenlifesciences offers products and services including Pharmacovigilance Services, Safety Database Management, Adverse Events Reporting, Risk Management Services, and Regulatory Intelligence. Its focus areas include Pharmacovigilance, Drug Safety, Adverse Events Reporting and Medical Devices.
Company details
Vizen Life Sciences offers comprehensive pharmacovigilance services such as adverse event reporting, risk management, and regulatory compliance for pharmaceutical and medical device companies. They operate from offices in Telangana, India, and the Czech Republic, assisting clients globally with safety database management, literature searches, and data migration to ensure adherence to international standards and improve patient safety.
- Headquarters India
- Employees 116
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vizenlifesciences.com
- Social LinkedIn
- Legal Name Vizen Life Sciences Private Limited
- Date of Incorporation 09 Sep, 2021
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹13.73 Cr
FY 2023 · +100311% YoY
- Net Profit₹4.13 Cr
FY 2023 · 30% margin
- EBITDA₹5.85 Cr
FY 2023 · 43% margin
- Employee Count116
Associated legal entities of Vizenlifesciences
Vizenlifesciences operates through Vizen Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vizen Life Sciences Private Limited CIN U24230TG2021PTC154785 | Active | 09 Sep 2021 | Hyderabad, Telangana | ₹13.7 Cr | 116 | 3 | View details |
Products & Services of Vizenlifesciences
Vizenlifesciences offers a comprehensive portfolio of products and services, including Pharmacovigilance Services, Safety Database Management, Adverse Events Reporting, Risk Management Services, and Regulatory Intelligence.
Monitoring and reporting of adverse drug events for compliance
Handling pharmacovigilance data migration and maintenance
Processing and submitting adverse event reports to authorities
Identifying and managing safety risks in pharmaceuticals
Providing ongoing monitoring of regulatory guidelines
Board of directors of Vizen Life Sciences Private Limited (Vizenlifesciences)
Vizen Life Sciences Private Limited is the primary company behind Vizenlifesciences. The board of Vizen Life Sciences Private Limited currently have 3 directors; the longest-serving is Laxmi Sairam Kumar Ambati, appointed in 2021. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Laxmi Sairam Kumar Ambati DIN 09312836 | Director | 09 Sep 2021 | 5 yrs 1 mo | Vizen Life Sciences Private Limited |
| Shanmukhapriya Ambati DIN 09312837 | Director | 09 Sep 2021 | 5 yrs 1 mo | Vizen Life Sciences Private Limited |
| Padmaja Ambati DIN 09527530 | Director | 17 Mar 2022 | 4 yrs 7 mo | Vizen Life Sciences Private Limited |
Financials of Vizenlifesciences
Figures of Vizen Life Sciences Private Limited, the primary company behind Vizenlifesciences, for FY 2023. Revenue was ₹13.73 Cr (+100311% year on year). Net profit was ₹4.13 Cr (30% margin). EBITDA was ₹5.85 Cr (43% margin).
- ₹13.73 CrRevenue · FY 2023 · +100311% YoY
- ₹4.13 CrNet profit · 30% margin
- ₹5.85 CrEBITDA · 43% margin
- ₹1 LakhPaid-up capital
- 116Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Vizen Life Sciences Private Limited are on its company page.
Detailed financial statements for Vizenlifesciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Vizenlifesciences
The website of Vizenlifesciences (vizenlifesciences.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 11.5% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Vizenlifesciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vizenlifesciences
Vizenlifesciences is headquartered in India.
Vizenlifesciences has 116 employees.
The primary company behind Vizenlifesciences, Vizen Life Sciences Private Limited, reported revenue of ₹13.73 Cr for FY 2023, up 100311% year on year.
Vizen Life Sciences offers comprehensive pharmacovigilance services such as adverse event reporting, risk management, and regulatory compliance for pharmaceutical and medical device companies. They operate from offices in Telangana, India, and the Czech Republic, assisting clients globally with safety database management, literature searches, and data migration to ensure adherence to international standards and improve patient safety.
Vizenlifesciences offers Pharmacovigilance Services, Safety Database Management, Adverse Events Reporting, Risk Management Services, and Regulatory Intelligence.
Vizenlifesciences operates through Vizen Life Sciences Private Limited.
The legal entities of Vizenlifesciences currently have 3 directors, including Laxmi Sairam Kumar Ambati, Shanmukhapriya Ambati, Padmaja Ambati.